Close



Feb 28, 2024 04:05PM
Nov 1, 2023 04:05PM
Aug 2, 2023 04:05PM
Jun 22, 2023 02:30PM
May 15, 2023 01:58PM
May 2, 2023 04:05PM
Feb 28, 2023 04:05PM Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2022 Financial Results and Recent Corporate Developments
Jan 5, 2023 08:31AM
Jan 5, 2023 08:30AM
Nov 2, 2022 04:05PM
Aug 2, 2022 04:05PM
May 4, 2022 04:05PM
Mar 1, 2022 04:05PM
Nov 3, 2021 04:01PM Sarepta Therapeutics Announces Third Quarter 2021 Financial Results and Recent Corporate Developments
Oct 14, 2021 05:44AM
Oct 13, 2021 09:15PM
Oct 12, 2021 04:38PM
Oct 12, 2021 04:01PM
Oct 12, 2021 04:01PM
Aug 4, 2021 04:05PM
May 5, 2021 04:05PM Sarepta Therapeutics Announces First Quarter 2021 Financial Results and Recent Corporate Developments
Apr 26, 2021 04:05PM
Mar 2, 2021 09:28AM
Mar 1, 2021 05:35PM
Mar 1, 2021 04:05PM
Jan 8, 2021 09:30AM
Jan 7, 2021 05:41PM
Nov 5, 2020 04:05PM Sarepta Therapeutics Announces Third Quarter 2020 Financial Results and Recent Corporate Developments
Aug 5, 2020 04:05PM
May 6, 2020 04:05PM
Feb 26, 2020 04:05PM
Feb 25, 2020 11:03AM
Dec 24, 2019 06:35AM
Dec 23, 2019 08:44AM
Dec 23, 2019 01:18AM Sarepta Therapeutics (SRPT) Enters Partnership with Roche for SRP-9001 Outside the U.S.; Receives $1.15B Upfront
Dec 23, 2019 01:00AM
Dec 23, 2019 01:00AM
Nov 7, 2019 04:05PM
Oct 15, 2019 08:37PM
Oct 9, 2019 08:00AM
Oct 2, 2019 09:07PM
Sep 25, 2019 08:06PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Nektar Therapeutics, Valaris, Sarepta Therapeutics, and Canada Goose and Encourages Investors to Contac
Sep 18, 2019 08:01PM
Aug 20, 2019 09:16AM
Aug 7, 2019 04:05PM
May 8, 2019 04:05PM
Mar 6, 2019 05:56AM
Mar 5, 2019 07:32PM
Mar 5, 2019 04:03PM Sarepta Therapeutics (SRPT) to Offer $350M in Common Stock
Mar 5, 2019 04:02PM

924,278 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All